Results
1 -
10 of
12
(Click
here to explore results)
- Cutaneous Photoaging, CHAPTER 6 Pigmentation and Photoaging. Desmond J. Tobin
, 2019
, Pages 145-166
- Allosterism in Drug Discovery, CHAPTER 9 Positive Allosteric Modulators of Opioid Receptors. Kristin L. Rockwell, Andrew Alt
, 2017
, Pages 194-219
- Glossary of Terms Used in Molecular Toxicology, Terms Beginning with P
, 2020
, Pages 256-289
- Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls, Chapter 12 Transport, Stability and Delivery Considerations for the Design of Peptide Drugs. Tomi Sawyer, Jerome Hochman, Suzanne M. D'Addio, Brad Sherborne, Marian E. Gindy
, 2019
, Pages 421-471
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 4 Peptide Library Technologies: Mixture-Based Library Generation and Screening. Colette T. Dooley
, 2017
, Pages 116-140
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 1 Renaissance in Peptide Drug Discovery: The Third Wave. Tomi K. Sawyer
, 2017
, Pages 1-34
- Metabolism of Nutrients by Gut Microbiota, CHAPTER 8 The Gut Microbiome and Metabolic Surgery. Mehdi Chaib, Matthew J. Davis, Stacey Kubovec, Liza Makowski, Joseph F. Pierre
, 2022
, Pages 173-195
- Drug Discovery for Psychiatric Disorders, CHAPTER 11 Modulation of HPA Axis Function for Treatment of Mood Disorders. Shaun P. Brothers, Claes Wahlestedt, Charles B. Nemeroff
, 2012
, Pages 276-299
- Capillary Electrophoresis–Mass Spectrometry for Metabolomics, CHAPTER 5 Stacking or On-line Sample Concentration in CE-MS for Metabolomics. Alain Wuethrich, Joselito P. Quirino
, 2018
, Pages 83-112
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 3 Peptide Biomarkers and Assay Development. N. K. Rana, M. Phillips, E. Carrión, G. Luisi, D. Sabatino
, 2017
, Pages 76-115